Subscribe for $2

Subscribe for 2 $

Financial Data API

Terminal Financial Data API

Theratechnologies Aktie News & Pressemeldungen

Theratechnologies Eulerpool News

12/5/2024, 2:21:31 PM

Theratechnologies sichert sich Exklusivrecht für innovative RNA-Medikamente in Kanada

1

1

Theratechnologies Stock News

Theratechnologies is being monitored by journalists and investors worldwide. We gather the latest Theratechnologies news here.

January 9 ·
Yahoo
Theratechnologies Provides Update on EGRIFTA SV® Supply
December 10 ·
Yahoo
Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA
December 9 ·
Yahoo
Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer
December 4 ·
Yahoo
Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada
November 26 ·
Yahoo
Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review
November 25 ·
Yahoo
Theratechnologies Inc. (TSE:TH) Has Found A Path To Profitability
October 17 ·
Yahoo
Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab
October 17 ·
Yahoo
Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance
October 11 ·
Yahoo
Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
October 10 ·
Yahoo
Theratechnologies Up 12% in U.S. Premarket Trading After Reporting Q3 Swing to Profit

1

2

1

2

Theratechnologies Stock Press Releases

Theratechnologies regularly publishes news on the company's website that are relevant for investors.

Access the world's leading financial data and tools

Subscribe for $2